Links between Fibrogenesis and CancerEsteban C. Gabazza Tissue fibrosis may occur for unknown causes or be the consequence of many pathological conditions including chronic inflammatory or infectious diseases, autoimmune disorders, graft rejection, or malignancy. On the other hand, malignant tumors have been identified in fibrotic tissues decades ago, and now accumulating evidence suggests that fibrotic lesions enhance the risk of cancer in several organs such as liver, lungs, and breast. Disruption of an organ parenchymal cells and of its normal structural scaffold during tissue fibrogenesis appears to induce loss of cell polarity, promoting uncontrolled cell proliferation that may eventually lead to cancer development. Many cellular and molecular abnormalities including aberrant expression of microRNAs, genetic and epigenetic alterations, evasion or delayed apoptosis, unregulated intracellular signal pathways, and dysregulation or defective intercellular communications have been proposed to explain this link between fibrogenesis and carcinogenesis. However, the precise mechanisms of this fibrosis-to-cancer transition remain unclear. This book presents a collection of reviews and original articles summarizing recent advances in understanding the molecular mechanisms of cancer development in fibrotic organs. |
Common terms and phrases
activation apoptosis associated binding Biol breast cancer CAFs cancer cells Chen chronic Clin clinical collagen compared components contribute CrossRef CrossRef][PubMed cytokines decreased differentiation disease drug effects enhanced et al expression fibroblasts Figure function gene genetic glucose growth factor hepatic hepatocellular carcinoma hepatocytes HSCs human idiopathic pulmonary fibrosis immune increased induces inflammation inflammatory inhibitor inhibits injury invasion involved kinase leading levels liver liver fibrosis lung cancer markers matrix mechanisms mediates metastasis mice microenvironment migration molecular mutations myofibroblasts overexpression patients platelet-derived growth factor potential present production progression proliferation promotes protein PubMed recent receptor reduced regulation reported response role secretion showed shown signaling pathway specific stimulates stromal suggest target therapeutic therapy tissue transcription transition treatment tumor Upregulation uterine Wang YAP/TAZ Zhang